Words that appeared in my mind where bio business is concerned are R and D, expensive, only in the developed world, ever-changing and profit driven. Sow at exactly is bio business? According to prof, it is the commercial activity based on the understanding of life sciences and life science processes, such as bio medical and agri-veterinary. Unfortunately, our class discussions and presentations circles around medical healthcare which I feel would be easy to relate to since it is closer to us.
As we all know, the bio business revolution will transform our lives and our economies and may well be our best hope for achieving sustainable development. Think about how our healthcare, food and energy resources have changed. Surgery used to be open but now surgery is done without slicing method. Food is now standardising in size and shape as genetic modification method was used.
Today’s lesson was also bombarded with readings but the one that I particularly like is reading 4, entitled “Will disruptive innovations cure health care” by Clayton M.Christensen, Richard Bohmer, and John Kenagy. Before I read it, I took the word disruptive at face value and wonder how disruptive cure healthcare since they are from 2 different dimensions. Then when I read it, it gave me a whole new perspective. It talked about new innovations threatening old business models and how these new innovations that may ultimately raise the quality of health care for everyone was rejected not due to its innovation but due to the how it could disrupt other businesses. After all, the article points out those disruptive technologies have caused many of history’s best companies to plunge into crisis and ultimately fail. An example would be photocopy machine or cameras that took away the once highly professional jobs to amateur. Oh and I like the way the article use the phrase “return to days of corporate mainframe center”. So bio business is much like any other business where competition is at its peak and profit outweighs the philanthropic idea of helping people.
Something needs to be done and reading 5 clearly shows the solution to it. It uses an interesting comparison of economists versus biomedical. Many biomedical inventions failed because the pace of sustaining innovation nearly always outstrips the ability of customers to absorb it. People must first see the long term benefit of it for it to succeed. Thus, these companies will not survive without any help from the government body. It requires a right mix of incentives to safeguard the maximum benefit of safe and effective innovations and practice. We need should not embrace innovations that seek to lower the cost of medication and ensure that everyone can seek medication help should there be a need for it.
Therefore, both articles gave me great insights into the bio medical industry. It is like gaining knowledge from the backdoor, knowing something that the masses could not have known.
The question on medical tourism where people will shift to the less developed countries to seek for medical health if the bio medical field upgrades itself is not much of a debate. I think even if the medical field is cheap; people from developed countries would want a safe medication diagnosis and treatment. They definitely would not risk their lives so this explains why many foreigners particularly people from Indonesia are tapping on medical tourism in Singapore. I think it is more of trust in the medical field than cost. Of course, that applies to those who are not financial declined or burden.
The key takeaway that I had from this class was the bulb to imagine how our future bio business will be like. Whether it would be throat cutting or everyone would be on the same goal of trying to help elevate diseases and illness both from the poor and rich.
I rate this session 7 out of 10 because I could only get the perspective of bio business from the medical point of view.